fbpx
Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
POULTRY PORK
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis

.

Better protection shown with recommended Marek’s disease vaccine dose in two genetic lines

The recommended dose of two Marek’s disease virus (MDV) vaccines provided better protection in two genetic lines of meat-type chickens compared to a lower dose, the results of a recent study show, Tarsicio Villalobos, director of technical services, Zoetis, said at the AAAP conference.1

In their controlled study, investigators sought to determine if the origin and dose of CVI988-strain MDV vaccines affect the efficacy against an early challenge with very virulent (vv) MDV.

Commercial hatchery eggs from two different genetic lines were injected in ovo at 18 days of incubation. They received Vaccine A, a competitor product, or Zoetis’ Poulvac® Ovoline CVI. Each vaccine was administered at the higher recommended dose of 4,000 plaque-forming units or at a lower dose. At hatch, females were sorted out, injected with ceftiofur and transported to North Carolina State University, where they were challenged with the vvMDV strain 648A.

At 7 days of age, there were no significant differences in bodyweight between birds that received the high or low dose of either vaccine, but by 21 days of age, bodyweight was significantly better in birds that had received the full, recommended dose of Poulvac Ovoline CVI compared to a group of controls that were not vaccinated and challenged, Villalobos said.

In addition, protection against the challenge as determined by the presence of MD lesions was significantly better at 51 days of age in birds that had received the recommended dose of both vaccines compared to the low dose and control. Both vaccines at the full dose did not seem to be affected by the genetic lines used in the study, he said.

1 Villalobos T, et al. american Veterinary Medical Association Convention notes; American Association of Avian Pathologists Symposium, 2013, Chicago. Zoetis inc. study #05-11-70aQO.

 




Posted on January 15, 2014

tags: , ,
RELATED NEWS



You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.